Article
Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.
Gene - 15 Feb 2014
Tsirka Theodora, Boukouvala Sotiria, Agianian Bogos, Fakis Giannoulis
Abstract excerpt
Arylamine N-acetyltransferases (NATs) are polymorphic enzymes mediating the biotransformation of arylamine/arylhydrazine xenobiotics, including pharmaceuticals and environmental carcinogens. The NAT1 and NAT2 genes, and their many polymorphic variants, have been thoroughly studied in humans by pharmacogeneticists and cancer epidemiologists. However, little is known about the function of NAT homologues in other...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
